Grow Group UK
About Grapefruit Gift
Grapefruit Gift is the result of crossing the popular parental varieties Grapefruit Romulan and God's Gift.
Bred by 
Allele Genetics
This particular phenotype, selected by Allele Genetics, is more Grapefruit-leaning and expresses an extreme citrus rind terpene profile with subtle notes of earth, musk and diesel. Elevated terpenes include myrcene, caryophyllene, pinene and limonene. Grapefruit Gift produces potency of 25%+ THC and, under optimal conditions, can produce total THC levels close to 30%.
Grapefruit Gift is a uniquely flavourful cultivar with compact, dense and vibrant green flowers. Users can expect a sweet and tart flavour that is very similar to fresh grapefruit. The God's Gift parent passed on its short and stout structure to the Grapefruit Romulan, overall improving its structure and yield.
Description provided by Segra.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About SafriCanna Pty Ltd.
SafriCanna is pioneering the shift towards a future where South African medicinal cannabis is recognised in every corner of the globe.
SafriCanna is pioneering the shift towards a future where South African Medicinal Cannabis is recognised in every corner of the globe.
Our primary mandate is to develop a full suite of medicinal EU-GMP cannabis products with our aim being to distribute to the ever-growing international cannabis market.
The overseas medicinal cannabis marketplace serves as a perfect point of departure for SafriCanna due to the fact that the market is developed and going from strength-to-strength.
South Africa is home to some of the finest cannabis in the world. Our climate and growing methods enable us to produce products that could compete in any marketplace worldwide. Infiltrating the international cannabis landscape forms part of a bigger strategy that will then see SafriCanna diversifying its offering and catering to a broader consumer base.
South Africa is a predominantly untapped resource in the global Medicinal Cannabis market, and as our continent plays catch-up, not only on legalisation, but also on growth and distribution, SafriCanna aims to assert itself as South Africa’s premium, fully-integrated Medicinal Cannabis brand. The face of cannabis is changing, and as it continues to do so, the opportunity for SafriCanna to develop a premium, intrinsically South African offering is becoming more and more prevalent.
SafriCanna is pioneering the shift towards a future where South African medicinal cannabis is recognised in every corner of the globe.
safricanna.com
Further National Health-Service Information on